Symbols / BWAY $15.81 +3.13% BrainsWay Ltd.

Healthcare • Medical Devices • Israel • NGM
BWAY Chart
About

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. The company was founded in 2003 and is headquartered in Jerusalem, Israel.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 632.92M
Enterprise Value 518.75M Income 7.63M Sales 52.23M
Book/sh 2.00 Cash/sh 1.85 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E 87.83 Forward P/E 35.40 PEG —
P/S 12.12 P/B 7.92 P/C —
EV/EBITDA 88.51 EV/Sales 9.93 Quick Ratio 3.24
Current Ratio 3.83 Debt/Eq 9.31 LT Debt/Eq —
EPS (ttm) 0.18 EPS next Y 0.45 EPS Growth 3.91%
Revenue Growth 27.40% Earnings 2026-05-12 ROA 2.61%
ROE 11.26% ROIC — Gross Margin 75.42%
Oper. Margin 13.17% Profit Margin 14.62% Shs Outstand 40.03M
Shs Float 23.18M Short Float 0.30% Short Ratio 0.51
Short Interest — 52W High 16.24 52W Low 3.92
Beta — Avg Volume 189.05K Volume 85.07K
Target Price $15.33 Recom None Prev Close $15.33
Price $15.81 Change 3.13%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$15.33
Mean price target
2. Current target
$15.81
Latest analyst target
3. DCF / Fair value
$0.37
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$15.81
Low
$15.00
High
$16.00
Mean
$15.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-12 main HC Wainwright & Co. Buy → Buy $15
2026-01-26 main HC Wainwright & Co. Buy → Buy $30
2025-12-08 main HC Wainwright & Co. Buy → Buy $24
2025-11-13 main HC Wainwright & Co. Buy → Buy $18
2025-11-12 main Northland Capital Markets Outperform → Outperform $23
2025-08-25 reit HC Wainwright & Co. Buy → Buy $17
2025-08-14 main Northland Capital Markets Outperform → Outperform $19
2025-08-14 main HC Wainwright & Co. Buy → Buy $17
2025-06-12 reit HC Wainwright & Co. Buy → Buy $16
2025-06-09 reit HC Wainwright & Co. Buy → Buy $16
2025-03-12 reit HC Wainwright & Co. Buy → Buy $16
2024-12-23 reit HC Wainwright & Co. Buy → Buy $16
2024-10-21 reit HC Wainwright & Co. Buy → Buy $16
2024-10-03 main Northland Capital Markets Outperform → Outperform $13
2024-09-16 reit HC Wainwright & Co. Buy → Buy $16
2024-08-08 main HC Wainwright & Co. Buy → Buy $16
2024-08-07 main Northland Capital Markets Outperform → Outperform $11
2024-06-05 reit HC Wainwright & Co. Buy → Buy $15
2024-05-09 main Oppenheimer Outperform → Outperform $11
2024-05-09 main HC Wainwright & Co. Buy → Buy $15
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
52.23
+27.33%
41.02
+29.04%
31.79
+16.96%
27.18
Operating Revenue
52.23
+27.33%
41.02
+29.04%
31.79
+16.96%
27.18
Cost Of Revenue
12.84
+23.04%
10.44
+25.60%
8.31
+16.54%
7.13
Reconciled Cost Of Revenue
12.84
+23.04%
10.44
+43.95%
7.25
+19.82%
6.05
Gross Profit
39.39
+28.79%
30.58
+30.26%
23.48
+17.10%
20.05
Operating Expense
35.06
+20.12%
29.19
+2.65%
28.44
-13.12%
32.73
Research And Development
9.60
+33.56%
7.19
+7.88%
6.67
-13.19%
7.68
Selling General And Administration
25.46
+15.73%
22.00
+1.67%
21.64
-11.02%
24.32
Selling And Marketing Expense
18.93
+16.85%
16.20
+173.70%
5.92
-18.93%
7.30
General And Administrative Expense
6.53
+12.59%
5.80
-63.12%
15.72
-7.62%
17.02
Salaries And Wages
—
12.19
-6.68%
13.06
-4.60%
13.69
Other Gand A
6.53
+12.59%
5.80
+118.43%
2.65
-20.08%
3.32
Total Expenses
47.90
+20.89%
39.62
+7.84%
36.74
-7.82%
39.86
Operating Income
4.32
+210.78%
1.39
+128.05%
-4.96
+60.90%
-12.68
Total Operating Income As Reported
4.32
+210.78%
1.39
+128.05%
-4.96
+60.90%
-12.68
EBITDA
11.46
+69.83%
6.75
+363.41%
-2.56
+77.64%
-11.45
Normalized EBITDA
11.46
+69.83%
6.75
+396.27%
-2.28
+79.69%
-11.21
Reconciled Depreciation
1.54
-13.16%
1.77
+32.46%
1.34
-12.84%
1.53
EBIT
9.92
+99.38%
4.97
+227.63%
-3.90
+69.99%
-12.99
Total Unusual Items
—
0.95
+433.45%
-0.28
-16.39%
-0.24
Total Unusual Items Excluding Goodwill
—
0.95
+433.45%
-0.28
-16.39%
-0.24
Net Income
7.63
+161.31%
2.92
+169.60%
-4.20
+68.56%
-13.35
Pretax Income
7.71
+122.90%
3.46
+187.66%
-3.95
+69.73%
-13.03
Net Non Operating Interest Income Expense
3.39
+63.78%
2.07
+59.44%
1.30
+1312.15%
-0.11
Interest Expense Non Operating
2.21
+45.71%
1.52
+3058.33%
0.05
+4.35%
0.05
Net Interest Income
3.39
+63.78%
2.07
+59.44%
1.30
+1312.15%
-0.11
Interest Expense
2.21
+45.71%
1.52
+3058.33%
0.05
+4.35%
0.05
Interest Income Non Operating
5.60
+56.14%
3.58
+65.09%
2.17
+95.76%
1.11
Interest Income
5.60
+56.14%
3.58
+65.09%
2.17
+95.76%
1.11
Other Income Expense
—
0.95
+433.45%
-0.28
-16.39%
-0.24
Gain On Sale Of Security
—
0.95
+433.45%
-0.28
-16.39%
-0.24
Tax Provision
0.08
-85.69%
0.54
+114.34%
0.25
-20.32%
0.32
Tax Rate For Calcs
0.00
-93.58%
0.00
-32.38%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
0.00
0.00
+100.00%
-0.07
-16.39%
-0.06
Net Income Including Noncontrolling Interests
7.63
+161.31%
2.92
+169.60%
-4.20
+68.56%
-13.35
Net Income From Continuing Operation Net Minority Interest
7.63
+161.31%
2.92
+169.60%
-4.20
+68.56%
-13.35
Net Income From Continuing And Discontinued Operation
7.63
+161.31%
2.92
+169.60%
-4.20
+68.56%
-13.35
Net Income Continuous Operations
7.63
+161.31%
2.92
+169.60%
-4.20
+68.56%
-13.35
Normalized Income
7.63
+161.31%
2.92
+173.42%
-3.98
+69.77%
-13.16
Net Income Common Stockholders
7.63
+161.31%
2.92
+169.60%
-4.20
+68.56%
-13.35
Diluted EPS
—
0.09
+169.23%
-0.13
+67.50%
-0.40
Basic EPS
—
0.09
+169.23%
-0.13
+67.50%
-0.40
Basic Average Shares
—
32.46
+0.53%
32.28
-3.26%
33.37
Diluted Average Shares
—
32.46
+0.53%
32.28
-3.26%
33.37
Diluted NI Availto Com Stockholders
7.63
+161.31%
2.92
+169.60%
-4.20
+68.56%
-13.35
Depreciation Amortization Depletion Income Statement
—
0.40
+43.53%
0.28
-38.90%
0.46
Depreciation And Amortization In Income Statement
—
0.40
+43.53%
0.28
-38.90%
0.46
Depreciation Income Statement
—
0.40
+43.53%
0.28
-38.90%
0.46
Provision For Doubtful Accounts
—
0.57
+493.10%
-0.14
-151.60%
0.28
Rent Expense Supplemental
—
—
—
2.20
Total Other Finance Cost
—
1.23
+48.79%
0.83
-29.40%
1.17
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
112.92
+19.72%
94.32
+49.77%
62.97
-2.33%
64.48
Current Assets
84.89
+6.55%
79.67
+43.64%
55.47
-4.52%
58.09
Cash Cash Equivalents And Short Term Investments
69.13
-0.31%
69.34
+50.80%
45.98
-3.35%
47.58
Cash And Cash Equivalents
67.70
-2.37%
69.34
+559.17%
10.52
-77.89%
47.58
Cash Equivalents
—
55.28
0.00
-100.00%
40.27
Cash Financial
—
14.07
+33.73%
10.52
+43.97%
7.31
Other Short Term Investments
1.43
0.00
-100.00%
35.47
0.00
Receivables
4.11
-10.55%
4.60
+21.59%
3.78
-21.97%
4.84
Accounts Receivable
4.11
-10.55%
4.60
+21.59%
3.78
-21.97%
4.84
Gross Accounts Receivable
—
5.76
+22.93%
4.68
-21.21%
5.95
Allowance For Doubtful Accounts Receivable
—
-1.16
-28.54%
-0.90
+17.89%
-1.10
Other Receivables
—
—
—
0.61
Inventory
7.13
+61.18%
4.43
+19.07%
3.72
-3.13%
3.84
Raw Materials
—
2.79
+56.06%
1.79
-30.18%
2.56
Work In Process
—
0.21
-82.82%
1.21
-26.65%
1.65
Finished Goods
—
2.57
+40.37%
1.83
+49.39%
1.23
Prepaid Assets
—
—
—
—
Restricted Cash
0.25
-7.38%
0.27
+0.00%
0.27
+0.00%
0.27
Other Current Assets
4.26
+312.89%
1.03
-39.72%
1.71
+10.03%
1.56
Total Non Current Assets
28.03
+91.37%
14.65
+95.10%
7.51
+17.52%
6.39
Net PPE
12.17
+1.84%
11.95
+106.36%
5.79
+8.31%
5.35
Gross PPE
12.17
-32.71%
18.08
+49.63%
12.09
+11.45%
10.84
Accumulated Depreciation
—
-6.13
+2.54%
-6.29
-14.52%
-5.50
Properties
—
0.00
0.00
0.00
Buildings And Improvements
—
5.29
+1686.82%
0.30
—
Machinery Furniture Equipment
—
2.51
+30.83%
1.92
+27.91%
1.50
Other Properties
12.17
+23.06%
9.89
+1.24%
9.77
+5.46%
9.26
Leases
—
0.39
+286.27%
0.10
+25.93%
0.08
Investments And Advances
14.34
—
—
—
Non Current Deferred Assets
—
1.06
+28.38%
0.83
+200.00%
0.28
Non Current Deferred Taxes Assets
—
1.06
+28.38%
0.83
+200.00%
0.28
Non Current Prepaid Assets
—
1.64
+83.91%
0.89
+16.06%
0.77
Other Non Current Assets
1.52
—
—
1.04
Total Liabilities Net Minority Interest
39.70
+24.04%
32.00
+49.61%
21.39
+12.11%
19.08
Current Liabilities
22.16
+44.42%
15.35
+57.22%
9.76
+19.90%
8.14
Payables And Accrued Expenses
8.86
+45.91%
6.07
+53.62%
3.95
+12.75%
3.50
Payables
8.86
+153.45%
3.50
+137.43%
1.47
+23.08%
1.20
Accounts Payable
2.43
-15.34%
2.87
+278.36%
0.76
-32.08%
1.12
Other Payable
6.43
+2472.00%
0.25
+63.40%
0.15
—
Current Accrued Expenses
—
2.58
+3.87%
2.48
+7.41%
2.31
Pensionand Other Post Retirement Benefit Plans Current
—
2.72
+31.91%
2.06
+10.55%
1.87
Total Tax Payable
—
0.27
-46.83%
0.50
0.00
Income Tax Payable
—
0.27
-46.83%
0.50
—
Current Debt And Capital Lease Obligation
1.07
+30.46%
0.82
+255.17%
0.23
-0.85%
0.23
Current Capital Lease Obligation
1.07
+30.46%
0.82
+255.17%
0.23
-0.85%
0.23
Current Deferred Liabilities
12.23
+113.55%
5.73
+63.07%
3.51
+137.78%
1.48
Current Deferred Revenue
12.23
+113.55%
5.73
+63.07%
3.51
+137.78%
1.48
Other Current Liabilities
—
—
1.01
-4.64%
1.06
Total Non Current Liabilities Net Minority Interest
17.53
+5.26%
16.66
+43.22%
11.63
+6.32%
10.94
Long Term Debt And Capital Lease Obligation
5.74
+19.63%
4.80
+1908.37%
0.24
-5.91%
0.25
Long Term Capital Lease Obligation
5.74
+19.63%
4.80
+1908.37%
0.24
-5.91%
0.25
Non Current Deferred Liabilities
11.79
+25.06%
9.43
-17.23%
11.39
+143.97%
4.67
Non Current Deferred Revenue
11.79
+25.06%
9.43
-17.23%
11.39
+143.97%
4.67
Other Non Current Liabilities
—
—
6.08
+1.01%
6.02
Stockholders Equity
73.22
+17.51%
62.31
+49.86%
41.58
-8.41%
45.40
Common Stock Equity
73.22
+17.51%
62.31
+49.86%
41.58
-8.41%
45.40
Capital Stock
0.43
+4.12%
0.41
+12.53%
0.37
+0.82%
0.36
Common Stock
0.43
+4.12%
0.41
+12.53%
0.37
+0.82%
0.36
Share Issued
39.16
+4.08%
37.63
+13.19%
33.24
+0.57%
33.05
Ordinary Shares Number
39.16
+4.08%
37.63
+13.19%
33.24
+0.57%
33.05
Additional Paid In Capital
162.22
+2.93%
157.60
+12.29%
140.34
+1.59%
138.15
Retained Earnings
-90.75
+7.76%
-98.38
+2.88%
-101.30
-4.32%
-97.11
Gains Losses Not Affecting Retained Earnings
-2.19
+0.00%
-2.19
+0.00%
-2.19
+0.00%
-2.19
Other Equity Adjustments
—
—
—
—
Total Equity Gross Minority Interest
73.22
+17.51%
62.31
+49.86%
41.58
-8.41%
45.40
Total Capitalization
73.22
+17.51%
62.31
+49.86%
41.58
-8.41%
45.40
Working Capital
62.73
-2.48%
64.32
+40.74%
45.70
-8.50%
49.95
Invested Capital
73.22
+17.51%
62.31
+49.86%
41.58
-8.41%
45.40
Total Debt
6.82
+21.21%
5.62
+1094.06%
0.47
-3.48%
0.49
Capital Lease Obligations
6.82
+21.21%
5.62
+1094.06%
0.47
-3.48%
0.49
Net Tangible Assets
73.22
+17.51%
62.31
+49.86%
41.58
-8.41%
45.40
Tangible Book Value
73.22
+17.51%
62.31
+49.86%
41.58
-8.41%
45.40
Available For Sale Securities
14.34
—
—
—
Derivative Product Liabilities
0.00
-100.00%
2.43
0.00
—
Dueto Related Parties Current
—
0.11
+91.23%
0.06
-28.75%
0.08
Foreign Currency Translation Adjustments
-2.19
+0.00%
-2.19
+0.00%
-2.19
+0.00%
-2.19
Inventories Adjustments Allowances
—
-1.15
-2.86%
-1.12
+30.39%
-1.61
Investmentin Financial Assets
14.34
—
—
—
Other Equity Interest
3.51
-28.04%
4.87
+11.74%
4.36
-29.45%
6.18
Other Inventories
—
—
—
3.84
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
18.02
+74.99%
10.30
+702.02%
1.28
+113.16%
-9.76
Cash Flow From Continuing Operating Activities
18.02
+74.99%
10.30
+702.02%
1.28
+113.16%
-9.76
Net Income From Continuing Operations
7.63
+161.31%
2.92
+169.60%
-4.20
+68.56%
-13.35
Depreciation Amortization Depletion
1.54
-13.16%
1.77
+32.46%
1.34
-12.84%
1.53
Depreciation
1.54
-13.16%
1.77
+32.46%
1.34
-12.84%
1.53
Depreciation And Amortization
1.54
-13.16%
1.77
+32.46%
1.34
-12.84%
1.53
Other Non Cash Items
-3.39
-63.78%
-2.07
-104.15%
-1.01
-388.60%
0.35
Stock Based Compensation
1.20
-17.00%
1.44
+278.22%
0.38
-74.15%
1.47
Asset Impairment Charge
0.04
-97.30%
1.52
+4.98%
1.45
+77.33%
0.82
Deferred Tax
0.08
-85.69%
0.54
+114.34%
0.25
-20.32%
0.32
Deferred Income Tax
0.08
-85.69%
0.54
+114.34%
0.25
-20.32%
0.32
Change In Working Capital
7.59
+217.80%
2.39
+45.99%
1.64
+212.45%
-1.45
Change In Receivables
0.61
+170.01%
-0.87
-179.61%
1.09
-25.21%
1.46
Changes In Account Receivables
0.61
+170.01%
-0.87
-179.61%
1.09
-25.21%
1.46
Change In Inventory
-1.99
-116.20%
-0.92
-81.82%
-0.51
+85.92%
-3.60
Change In Payables And Accrued Expense
0.24
-89.28%
2.25
+948.30%
-0.27
-188.93%
0.30
Change In Payable
0.24
-89.28%
2.25
+948.30%
-0.27
-188.93%
0.30
Change In Account Payable
-0.48
-122.51%
2.12
+748.01%
-0.33
0.00
Change In Other Working Capital
9.25
+3240.79%
0.28
-83.00%
1.63
+106.20%
0.79
Change In Other Current Assets
-0.53
-131.96%
1.65
+628.53%
-0.31
+22.58%
-0.40
Investing Cash Flow
-17.49
-157.71%
30.31
+181.03%
-37.41
-188.71%
42.17
Cash Flow From Continuing Investing Activities
-17.49
-157.71%
30.31
+181.03%
-37.41
-188.71%
42.17
Net PPE Purchase And Sale
-1.75
+53.95%
-3.79
-58.94%
-2.39
-223.30%
1.94
Purchase Of PPE
-1.75
+53.95%
-3.79
—
—
Capital Expenditure
-1.75
+53.95%
-3.79
-58.94%
-2.39
—
Net Investment Purchase And Sale
-15.77
-146.33%
34.03
+197.16%
-35.02
-187.05%
40.23
Purchase Of Investment
-15.77
-1523.69%
-0.97
+97.23%
-35.02
-166671.43%
-0.02
Sale Of Investment
0.00
-100.00%
35.00
0.00
-100.00%
40.25
Net Other Investing Changes
0.02
-73.68%
0.08
—
—
Financing Cash Flow
-2.21
-112.12%
18.26
+1880.02%
-1.03
+33.68%
-1.55
Cash Flow From Continuing Financing Activities
-2.21
-112.12%
18.26
+1880.02%
-1.03
+33.68%
-1.55
Net Issuance Payments Of Debt
-0.83
-96.23%
-0.42
-56.46%
-0.27
+49.16%
-0.53
Repayment Of Debt
-0.83
-96.23%
-0.42
-56.46%
-0.27
+49.16%
-0.53
Long Term Debt Payments
-0.83
-96.23%
-0.42
-56.46%
-0.27
+49.16%
-0.53
Net Long Term Debt Issuance
-0.83
-96.23%
-0.42
-56.46%
-0.27
+49.16%
-0.53
Net Common Stock Issuance
0.00
-100.00%
16.35
0.00
+100.00%
-0.05
Common Stock Payments
—
0.00
0.00
+100.00%
-0.05
Repurchase Of Capital Stock
—
0.00
0.00
+100.00%
-0.05
Proceeds From Stock Option Exercised
0.00
-100.00%
3.44
0.00
0.00
Net Other Financing Charges
-1.38
-24.73%
-1.11
-46.75%
-0.76
+21.52%
-0.96
Changes In Cash
-1.69
-102.87%
58.87
+258.47%
-37.15
-220.38%
30.86
Effect Of Exchange Rate Changes
0.04
+189.36%
-0.05
-152.22%
0.09
+144.55%
-0.20
Beginning Cash Position
69.34
+559.17%
10.52
-77.89%
47.58
+181.19%
16.92
End Cash Position
67.70
-2.37%
69.34
+559.17%
10.52
-77.89%
47.58
Free Cash Flow
16.27
+150.20%
6.50
+689.66%
-1.10
+88.70%
-9.76
Common Stock Issuance
0.00
-100.00%
16.35
0.00
0.00
Interest Paid CFO
-0.11
+9.68%
-0.12
+50.99%
-0.25
-450.00%
-0.05
Interest Received CFO
4.08
+39.70%
2.92
+71.18%
1.71
+63.82%
1.04
Issuance Of Capital Stock
0.00
-100.00%
16.35
0.00
0.00
Taxes Refund Paid
-0.63
+37.17%
-1.01
-9072.73%
-0.01
+97.52%
-0.44
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category